Cargando…
Consolidation chemotherapy during neoadjuvant chemoradiation (CRT) for distal rectal cancer leads to sustained decrease in tumor metabolism when compared to standard CRT regimen
BACKGROUND: Neoadjuvant CRT may lead to significant tumor regression in patients with rectal cancer. Different CRT regimens with consolidation chemotherapy may lead to increased rates of complete tumor regression. The purpose of this study was to understand tumor metabolic activity following two dif...
Autores principales: | Habr-Gama, Angelita, Perez, Rodrigo O., São Julião, Guilherme P., Proscurshim, Igor, Fernandez, Laura M., Figueiredo, Marleny N., Gama-Rodrigues, Joaquim, Buchpiguel, Carlos A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766749/ https://www.ncbi.nlm.nih.gov/pubmed/26911200 http://dx.doi.org/10.1186/s13014-016-0598-6 |
Ejemplares similares
-
The Effects of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer—The Impact in Intratumoral Heterogeneity
por: Bettoni, Fabiana, et al.
Publicado: (2019) -
Watch and Wait Approach for Rectal Cancer
por: Cerdan-Santacruz, Carlos, et al.
Publicado: (2023) -
A multi-centre randomized controlled trial investigating Consolidation Chemotherapy with and without oxaliplatin in distal rectal cancer and Watch & Wait
por: Habr-Gama, Angelita, et al.
Publicado: (2023) -
CRT-D or CRT-P in CRT-indicated patients?
por: Kaya, Adnan, et al.
Publicado: (2017) -
CRT-D or CRT-P?: the endless debate!
por: Daubert, J Claude
Publicado: (2023)